STOCK TITAN

Fortrea (FTRE) Form 4: Director Erin Russell Buys 9,854 Shares

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Erin L. Russell, a director of Fortrea Holdings Inc. (FTRE), purchased 9,854 shares of the company's common stock on 09/02/2025 at a weighted average price of $10.15 per share. The Form 4 reports the shares as directly beneficially owned and notes the aggregate holding after the transaction is 9,854 shares. The filing states the trade was executed in multiple trades at prices ranging from $10.12 to $10.16 and that full trade details will be provided upon request. The Form 4 was signed by an attorney-in-fact for Ms. Russell.

Positive

  • Director purchase reported, showing insider acquisition of 9,854 FTRE shares on 09/02/2025 at a weighted average price of $10.15
  • Complete execution disclosure including price range $10.12–$10.16 and willingness to provide full trade details upon request

Negative

  • No material negative items disclosed in this Form 4; no derivatives or broader plans were reported that would indicate larger strategic positioning

Insights

TL;DR: Director purchase of 9,854 FTRE shares at $10.15 signals a modest insider buy, with limited immediate market impact given the size disclosed.

The reported acquisition is a straightforward open-market purchase totaling 9,854 shares at a weighted average price of $10.15, executed on 09/02/2025. The filing clarifies execution prices ranged $10.12–$10.16 and the shares are held directly by the reporting person. Because the Form 4 shows only this single non-derivative transaction and the aggregate post-transaction holding equals the shares purchased, the trade appears to be a personal purchase rather than part of a larger plan disclosed here. Materiality is constrained by the absolute share count and absence of related transactions or derivative positions in this filing.

TL;DR: Disclosure is complete for the reported trade; signature by attorney-in-fact and execution-price range are properly noted.

The Form 4 provides required details: reporting person identity and address, relationship to the issuer (Director), transaction date, transaction code (P for purchase), the number of shares, weighted average price, and aggregate beneficial ownership. The explanation itemizes price range and offers to provide trade-level breakdowns if requested, which aligns with transparency expectations. The filing contains no amendments or additional arrangements disclosed.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Russell Erin L

(Last) (First) (Middle)
8 MOORE DRIVE

(Street)
DURHAM NC 27709

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Fortrea Holdings Inc. [ FTRE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 09/02/2025 P 9,854 A $10.15(2) 9,854(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The purchases reported on this Form 4 represent shares of Common Stock purchased by the Reporting Person.
2. This transaction was executed in multiple trades at prices ranging from $10.12 to $10.16. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. This number reflects the aggregate amount of Common Stock held by the reporting person.
/s/ James Stillman Hanson, Attorney-in-Fact for Erin L. Russell 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Erin L. Russell report on the Form 4 for FTRE?

Ms. Russell reported purchasing 9,854 shares of Fortrea Holdings Inc. common stock on 09/02/2025 at a weighted average price of $10.15 per share.

How many FTRE shares does the reporting person own after the transaction?

The Form 4 reports aggregate beneficial ownership of 9,854 shares following the reported purchase.

What price range was disclosed for the FTRE purchase?

Execution prices ranged from $10.12 to $10.16; the filing lists $10.15 as the weighted average purchase price.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by James Stillman Hanson as attorney-in-fact for Erin L. Russell on 09/04/2025.

Was the transaction part of a derivative or 10b5-1 plan?

No derivative securities or 10b5-1 plan indication were reported in this Form 4; the filing shows a direct purchase (transaction code P).
Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

FTRE Latest News

FTRE Latest SEC Filings

FTRE Stock Data

1.61B
91.87M
0.5%
111.46%
11.57%
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM